Globus Medical (GMED) Change in Cash (2011 - 2026)

Globus Medical (GMED) has 16 years of Change in Cash data on file, last reported at $34.8 million in Q1 2026.

• Quarterly Change in Cash rose 110.77% year-over-year to $34.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.7 million (down 7.01% YoY) and the FY2025 annual result came in at -$258.3 million, down 181.44% from the prior year.
• Change in Cash retreated to $34.8 million in Q1 2026, from $154.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $212.3 million in Q3 2024 to a low of -$323.2 million in Q1 2025.
• A 5-year average of $21.6 million and a median of $36.7 million in 2022 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2023 — Change in Cash jumped 1055.4% — and 2025, when it plunged 511.31%.
• Tracing GMED's Change in Cash over 5 years: stood at $16.2 million in 2022, then jumped by 1055.4% to $187.7 million in 2023, then dropped by 13.85% to $161.7 million in 2024, then slipped by 4.51% to $154.4 million in 2025, then tumbled by 77.46% to $34.8 million in 2026.
• The last three Change in Cash figures came in at $34.8 million (Q1 2026), $154.4 million (Q4 2025), and $142.3 million (Q3 2025), per Business Quant data.